Storia in 7 fonti

Definium LSD therapy helped patients with major depression in late-stage trial

Definium Therapeutics said that its LSD therapy helped patients with major depression in its first Phase 3 trial, bringing the psychedelic drug closer to a potential approval.

Raccontata da

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

statnews.comStai leggendo3 g fa

Definium LSD therapy helped patients with major depression in late-stage trial

Definium Therapeutics said that its LSD therapy helped patients with major depression in its first Phase 3 trial, bringing the psychedelic drug closer to a potential approval.

originale

endpoints.news3 g fa

Definium reports Phase 3 hit for LSD drug in severe form of depression

Definium's LSD drug DT120 hit its Phase 3 MDD primary endpoint, beating analyst expectations with significant improvement in depression symptoms.

Leggi questa versione → originale

gizmodo.com2 g fa

LSD Just Passed Its Biggest Test Yet for Treating Depression

Definium Therapeutics annuncia Phase III di DT120 (LSD proprietaria): singola dose raggiunge 35% remissione versus 7% placebo nella depressione clinica. Per manager tech il segnale è una terapia single-dose disruptive rispetto ai trattamenti cronici attuali, con impatto potenziale su employee wellness e healthcare spending aziendale.

Leggi questa versione → originale

medpagetoday.com1 g fa

LSD's Depression Win; Summer Heat and Suicide; Antipsychotic Nonresponse Predictors

News and commentary from the psychiatry world

Leggi questa versione → originale

investors.com2 g fa

Biotech Goes Sky-High After LSD Drug Treats Depression

One analyst called this a "best-case" scenario for the company's experimental depression treatment.

Leggi questa versione → originale

zerohedge.com3 g fa

Psychedelic Stocks Could Explode Higher

Definium's DT120 met Phase 3 for LSD-based depression therapy, driving DFTX +200% YTD with single-dose efficacy versus SSRIs. Policy-driven FDA expedited pathway opens M&A consolidation window; psychedelic therapeutics signal broader deregulation trend in healthcare.

Leggi questa versione → originale

Timeline cronologica

lunedì 22 giugno 2026·zerohedge.com
Psychedelic Stocks Could Explode Higher
Positive clinical data is starting to trickle in and Trump wants to fast-track the sector...
lunedì 22 giugno 2026·statnews.com
Definium LSD therapy helped patients with major depression in late-stage trial
Definium Therapeutics said that its LSD therapy helped patients with major depression in its first Phase 3 trial, bringing the psychedelic drug closer to a potential approval.
lunedì 22 giugno 2026·endpoints.news
Definium reports Phase 3 hit for LSD drug in severe form of depression
Definium's LSD drug DT120 hit its Phase 3 MDD primary endpoint, beating analyst expectations with significant improvement in depression symptoms.
lunedì 22 giugno 2026·investors.com
Biotech Goes Sky-High After LSD Drug Treats Depression
One analyst called this a "best-case" scenario for the company's experimental depression treatment.
lunedì 22 giugno 2026·zerohedge.com
Definium Soars As Much As 50% After LSD-Based Depression Drug Meets Late-Stage Clinical Trial Goal
DT120, a psychedelic that activates serotonin receptors, was generally well tolerated, with mostly mild side effects occurring on dosing day and no serious safety concerns.
lunedì 22 giugno 2026·gizmodo.com
LSD Just Passed Its Biggest Test Yet for Treating Depression
People taking Definium Therapeutics' DT120 showed long-lasting reductions in their depression symptoms compared to a placebo, the company announced Monday.
mercoledì 24 giugno 2026·biopharmadive.com
To Wall Street, psychedelics biotechs are more teammates than rivals
Some analysts argue that, even for competitors, a big clinical trial win for Definium Therapeutics helps validate the psychedelic field and “bring it even further into the…
mercoledì 24 giugno 2026·medpagetoday.com
LSD's Depression Win; Summer Heat and Suicide; Antipsychotic Nonresponse Predictors
News and commentary from the psychiatry world

Definium LSD therapy helped patients with major depression in late-stage trial

Definium reports Phase 3 hit for LSD drug in severe form of depression

LSD Just Passed Its Biggest Test Yet for Treating Depression

LSD's Depression Win; Summer Heat and Suicide; Antipsychotic Nonresponse Predictors

Biotech Goes Sky-High After LSD Drug Treats Depression

Psychedelic Stocks Could Explode Higher

Timeline cronologica

Psychedelic Stocks Could Explode Higher

Definium LSD therapy helped patients with major depression in late-stage trial

Definium reports Phase 3 hit for LSD drug in severe form of depression

Biotech Goes Sky-High After LSD Drug Treats Depression

Definium Soars As Much As 50% After LSD-Based Depression Drug Meets Late-Stage Clinical Trial Goal

LSD Just Passed Its Biggest Test Yet for Treating Depression

To Wall Street, psychedelics biotechs are more teammates than rivals

LSD's Depression Win; Summer Heat and Suicide; Antipsychotic Nonresponse Predictors

Definium LSD therapy helped patients with major depression in late-stage trial

Definium reports Phase 3 hit for LSD drug in severe form of depression

LSD Just Passed Its Biggest Test Yet for Treating Depression

LSD's Depression Win; Summer Heat and Suicide; Antipsychotic Nonresponse Predictors

Biotech Goes Sky-High After LSD Drug Treats Depression

Psychedelic Stocks Could Explode Higher

Timeline cronologica

Psychedelic Stocks Could Explode Higher

Definium LSD therapy helped patients with major depression in late-stage trial

Definium reports Phase 3 hit for LSD drug in severe form of depression

Biotech Goes Sky-High After LSD Drug Treats Depression

Definium Soars As Much As 50% After LSD-Based Depression Drug Meets Late-Stage Clinical Trial Goal

LSD Just Passed Its Biggest Test Yet for Treating Depression

To Wall Street, psychedelics biotechs are more teammates than rivals

LSD's Depression Win; Summer Heat and Suicide; Antipsychotic Nonresponse Predictors